Signal Advisors Wealth’s ResMed RMD Stock Holding History

Signal Advisors Wealth’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,621	Closed	-$363K	–	529
2025 Q1	$363K	Buy	1,621 +10	+0.6%	+$2.33K	0.04%	335
2024 Q4	$368K	Buy	1,611 +92	+6%	+$22.2K	0.04%	317
2024 Q3	$371K	Buy	+1,519	New	+$339K	0.05%	304

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Signal Advisors Wealth's RMD Position: Q2 2025 in Review

Signal Advisors Wealth sold out of ResMed (RMD) in Q2 2025, closing a stake of 1,621 shares — an estimated $363K sold.

Signal Advisors Wealth first reported a position in RMD in Q3 2024 and held it in 3 quarters. The position peaked at $371K in Q3 2024. 919 funds tracked by Wall St. Rank hold RMD as of Q2 2025.

Signal Advisors Wealth reported no remaining ResMed position as of Q2 2025 after selling out during the quarter.
Signal Advisors Wealth sold 1,621 ResMed shares in Q2 2025, an estimated $363K.
Signal Advisors Wealth first reported a position in ResMed in Q3 2024 and held it in 3 quarters.
Signal Advisors Wealth's ResMed position peaked at $371K in Q3 2024.
919 funds tracked by Wall St. Rank held ResMed as of Q2 2025.

Based on Signal Advisors Wealth's 13F filing for Q2 2025, filed 10 Jul 2025.